Abstract:Sir,We read with great interest the article published in Brain by Tezenas du Montcel et al. (2014) reporting modifying factors of age-at-onset in 1255 individuals affected with spinocerebellar ataxia (SCA) types 1, 2, 3, 6 and 7, recruited through the European Consortium on Spinocerebellar Ataxias (EUROSCA). We would like to report our findings on genetic modifiers and age-at-onset in 802 Chinese Han patients (429 males, 373 females) with Machado-Joseph disease (MJD/SCA3), on behalf of the Chinese Clinical Research Cooperative Group for Spinocerebellar Ataxias (CCRCG-SCA). Our study was approved by the ethics committee of Xiangya Hospital, Central South University. Blood samples were collected after written informed consent from all subjects. All MJD patients were genotyped for ATXN3 and nine other polyQ-related genes ( ATXN1 , ATXN2 , CACNA1A , ATXN7 , TBP , ATN1 , KCNN3 , RAI1 and HTT ). None of the MJD patients was a ‘homozygote’ (i.e. bearing two expanded alleles).We used a similar statistical strategy as described by the EUROSCA consortium (Tezenas du Montcel et al. , 2014). For some polyQ-related genes ( ATXN1 , TBP , ATN1 and HTT ), the sizes of the shorter and the longer alleles were considered (separately) as continuous variables; given the skewed distribution of allele size in the other genes ( ATXN2 , ATXN3 , ATXN7 , CACNA1A and RAI1 ) these were classified as short, short-medium, medium or long (Table 1). The interaction between both alleles, their mean length and the size difference between alleles at each locus were also considered as dependent variables. View this table:Table 1 Classification of polyQ-related normal alleles according to the number of CAG repeatsThe logarithmically transformed age-at-onset was treated as a dependent variable with homoscedasticity. Linear regression analysis (linear and quadratic effects) was performed to estimate the effect on age-at-onset of the expanded allele at ATXN3. Different models were then …

A Drosophila Model of the Neurodegenerative Disease SCA17 Reveals a Role of RBP-J/Su(H) in Modulating the Pathological Outcome.

Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration

dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1

Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis.

Progressive degeneration in a new Drosophila model of spinocerebellar ataxia type 7

The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless Proteins

Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.

Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila

Molecular Mechanisms and Therapeutics for SCA17

Cerebellum-Enriched Protein Inpp5a Contributes To Selective Neuropathology In Mouse Model Of Spinocerebellar Ataxias Type 17

Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways

Drosophila as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3

Insights into Dentatorubral-Pallidoluysian Atrophy from a new Drosophila model of disease

Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia Syndrome

Genetically Modified Rodent Models of SCA17

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice

Expanded Ggggcc Repeat Rna Associated With Amyotrophic Lateral Sclerosis And Frontotemporal Dementia Causes Neurodegeneration

The fly homolog of SUPT16H , a gene associated with neurodevelopmental disorders, is required in a cell-autonomous fashion for cell survival

A Drosophila Su(H) model of Adams-Oliver Syndrome reveals cofactor titration as a mechanism underlying developmental defects